Literature DB >> 25472783

Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.

S von Haehling, S H von Lanzenauer1, K Wolk2, C Höflich1, S Kunz3, B H Grünberg4, W-D Döcke4, U Reineke1, K Asadullah4, W Sterry5, H-D Volk1, R Sabat2.   

Abstract

Interleukin (IL)-10 is an important immunoregulatory cytokine that mediates its effects via a transmembrane receptor complex consisting of two different chains, IL-10R1 and IL-10R2. While IL-10R2 is ubiquitously expressed and does not bind IL-10 primarily, the expression of IL-10R1 determines cellular responsiveness. However, the current knowledge about the expression and regulation of IL-10R1 is still limited. Here we analyzed the expression of IL-10R1 on monocytic cells and demonstrated that human blood monocytes carried about 720 IL-10-binding sites on their surface. Compared with lymphocytes and various tissue cells and tissues, blood monocytes expressed the highest IL-10R1 levels. The in vitro differentiation of these cells into macrophages provoked a further increase of IL-10R1 surface expression. In contrast, their differentiation into myeloid dendritic cells (mDCs) resulted in reduced surface IL-10R1 levels. The different IL-10R1 levels expressed by monocyte-derived antigen-presenting cell populations were reflected in their different responsiveness toward IL-10. Importantly, also in vivo developed immature macrophages and mDCs showed different IL-10 sensitivity. These data suggest that, compared with monocytes and macrophages, mDCs partially escape from IL-10's inhibitory mechanisms by downregulating IL-10R1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25472783     DOI: 10.1038/gene.2014.69

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  51 in total

1.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

Authors:  Abdelilah Wakkach; Nathalie Fournier; Valérie Brun; Jean-Philippe Breittmayer; Françoise Cottrez; Hervé Groux
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

2.  An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.

Authors:  M Finsterbusch; V Khare; C Campregher; R Evstatiev; C Gasche
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

3.  Dendritic cells as the terminal stage of monocyte differentiation.

Authors:  K A Palucka; N Taquet; F Sanchez-Chapuis; J C Gluckman
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

4.  IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis.

Authors:  Ellen Witte; Georgios Kokolakis; Katrin Witte; Sandra Philipp; Wolf-Dietrich Doecke; Nina Babel; Bianca M Wittig; Katarzyna Warszawska; Agata Kurek; Magdalena Erdmann-Keding; Stefanie Kunz; Khusru Asadullah; Marshall E Kadin; Hans-Dieter Volk; Wolfram Sterry; Kerstin Wolk; Robert Sabat
Journal:  J Invest Dermatol       Date:  2014-07-21       Impact factor: 8.551

5.  A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity.

Authors:  S-Y Lin; S-C Hsieh; Y-C Lin; C-N Lee; M-H Tsai; L-C Lai; E Y Chuang; P-C Chen; C-C Hung; L-Y Chen; W S Hsieh; D-M Niu; Y-N Su; H-N Ho
Journal:  Genes Immun       Date:  2011-11-03       Impact factor: 2.676

Review 6.  IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties.

Authors:  Katrin Witte; Ellen Witte; Robert Sabat; Kerstin Wolk
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-23       Impact factor: 7.638

Review 7.  Biology of interleukin-10.

Authors:  Robert Sabat; Gerald Grütz; Katarzyna Warszawska; Stefan Kirsch; Ellen Witte; Kerstin Wolk; Jens Geginat
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-05       Impact factor: 7.638

8.  Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa.

Authors:  Kerstin Wolk; Katarzyna Warszawska; Conny Hoeflich; Ellen Witte; Sylke Schneider-Burrus; Katrin Witte; Stefanie Kunz; Annette Buss; Hans Joachim Roewert; Markus Krause; Ansgar Lukowsky; Hans-Dieter Volk; Wolfram Sterry; Robert Sabat
Journal:  J Immunol       Date:  2010-12-08       Impact factor: 5.422

9.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

10.  Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route.

Authors:  Fanny Edele; Jan C Dudda; Eva Bachtanian; Thilo Jakob; Hanspeter Pircher; Stefan F Martin
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

View more
  4 in total

1.  IL-10 Induced by mTNF Crosslinking-Mediated Reverse Signaling in a Whole Blood Assay Is Predictive of Response to TNFi Therapy in Rheumatoid Arthritis.

Authors:  Marco Krasselt; Natalya Gruz; Matthias Pierer; Christoph Baerwald; Ulf Wagner
Journal:  J Pers Med       Date:  2022-06-19

2.  Lactobacillus delivery of bioactive interleukin-22.

Authors:  Yin Lin; Kasper Krogh-Andersen; Lennart Hammarström; Harold Marcotte
Journal:  Microb Cell Fact       Date:  2017-08-23       Impact factor: 5.328

3.  Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-β Release.

Authors:  Elizabeth A Thompson; Patricia A Darrah; Kathryn E Foulds; Elena Hoffer; Alayna Caffrey-Carr; Sophie Norenstedt; Leif Perbeck; Robert A Seder; Ross M Kedl; Karin Loré
Journal:  Cell Rep       Date:  2019-07-30       Impact factor: 9.423

4.  The Efficacy of Lactocare® Synbiotic on the Clinical Symptoms in Patients with Psoriasis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Ali Akbarzadeh; Pedram Alirezaei; Amin Doosti-Irani; Maryam Mehrpooya; Fatemeh Nouri
Journal:  Dermatol Res Pract       Date:  2022-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.